Information Library
Flexible outsourcing - Outsourcing
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
Capital - sharing risks, expanding opportunities
July 14, 2010
This Capital brochure reviews how Quintiles helps biopharma allies maximize the value of assets, reduce risk, accelerate outcomes and increase rewards. -
Doctors and Sales Reps
July 7, 2010
Pharmaceutical companies are faced with a difficult question, should they invest in an inhouse sales force to market their product or does it make sense -
Outsourcing Exceeds Expectations
June 30, 2010
In Quintiles, Lilly found an ally with a kindred commitment to a best-in-class culture, plus a readiness to innovate in a challanging market. -
Syndicated Solutions
June 30, 2010
Astellas needed to rapidly ramp up its sales force by 50% to take advantage of a projected $1 billion opportunity. Quintiles provided a new risk -
Challenging Traditional Outsourcing Models Using Core And Non-Core Assessment
June 30, 2010
-
The New Health
May 26, 2010
Quintiles examines the complex challenges and opportunities facing the bio pharmaceutical industry and how companies must manage risk, demonstrate greater value and improve patient outcomes. -
Global Flexibility
May 9, 2010
PharmaMar faced a massive logistical challenge. It needed to quickly mobilize an effective sales force covering a market that spans several different national legislations and more than 20 official languages. With the help of Quintiles, on-time recruitment against aggressive timelines made it possible to top 2007 sales goals in the first year. -
Blockbuster Co-Promotion
May 9, 2010
A pharma company targeted seven countries for quickly promoting its new compound. Read how, in just four months, Quintiles recruited, trained and implemented highly effective field sales teams in all seven new countries. -
Agile Outsourcing
May 9, 2010
Imagine the challenge — a UK-based biotech company gains EMA (formerly known as EMEA) approval for a new compound, with no mainland European sales infrastructure -
Bridging Cultures
May 9, 2010
In 2008, the next stage in Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise.
